Understanding which blood tests are used in ovarian cancer detection is an important step in taking a proactive approach to women's health. Whether you have a family history of ovarian cancer, are experiencing unexplained symptoms, or simply want greater awareness of your health markers, blood testing can provide meaningful clinical data to guide conversations with appropriate healthcare professionals.
At Private Blood Tests London, our nurse-led clinic offers a range of diagnostic blood tests — including cancer marker profiles — to support informed, proactive health awareness. We provide testing and reporting only; we do not offer prescriptions, treatment, or specialist services.
What Are Ovarian Cancer Detection Blood Tests?
Ovarian cancer blood tests are laboratory analyses of specific proteins, hormones, and biomarkers found in the bloodstream. These markers can sometimes be elevated in individuals with ovarian cancer, though raised levels may also be associated with a range of benign conditions. Blood tests used in ovarian cancer screening are therefore considered *supportive tools* rather than standalone diagnostic instruments.
> Quick Definition: An ovarian cancer blood test measures specific biomarkers — most commonly CA-125 — that may be elevated in the presence of ovarian abnormalities. Results are interpreted alongside clinical assessment and are informational in nature, not diagnostic on their own.
Key Blood Biomarkers Associated with Ovarian Cancer Detection
CA-125 (Cancer Antigen 125)
The CA-125 blood test is the most widely recognised marker associated with ovarian cancer monitoring and detection. CA-125 is a protein produced by cells in the body, and elevated levels may indicate:
A normal CA-125 level is generally considered to be below 35 U/mL, though laboratory reference ranges may vary slightly. Elevated levels do not automatically confirm ovarian cancer, and normal levels do not categorically rule it out. This is why CA-125 results are best interpreted in conjunction with broader clinical evaluation.
Practical Insight: A raised CA-125 may suggest the presence of certain conditions and may prompt further investigation by an appropriate healthcare professional. It should not be used alone to draw conclusions about your health.
HE4 (Human Epididymis Protein 4)
HE4 is an emerging biomarker that may be used alongside CA-125 to provide a more comprehensive picture. Research suggests that HE4 may be elevated in cases of ovarian cancer, even when CA-125 levels remain within a normal range. Used together, CA-125 and HE4 can contribute to a more nuanced assessment of risk indicators.
AFP (Alpha-Fetoprotein) and hCG (Human Chorionic Gonadotropin)
For certain rarer subtypes of ovarian cancer — specifically germ cell tumours — markers such as AFP and hCG may be relevant. These are the same markers used in testicular cancer detection and are occasionally used in specific clinical contexts for ovarian evaluation.
Comparison Table: Common Blood Tests in Ovarian Cancer Detection
| Blood Test | Primary Role | Reference Range (Approx.) | Limitations |
|---|---|---|---|
| CA-125 | Most common ovarian marker | < 35 U/mL | Elevated in many benign conditions |
| HE4 | Complement to CA-125 | Varies by age/menopausal status | Less widely available |
| AFP | Germ cell tumour detection | < 10 ng/mL | Specific to certain tumour types |
| hCG | Germ cell tumour detection | < 5 mIU/mL | Specific to certain tumour types |
| CA 19-9 | Secondary marker support | < 37 U/mL | Not ovarian-specific |
Reference ranges are approximate and may vary between laboratories. All results must be interpreted in the context of individual health history.
Who Should Consider Ovarian Cancer Marker Testing?
Blood testing for ovarian cancer markers may be worth considering for women who:
Testing is not limited to those experiencing symptoms. Many individuals in London and across the UK seek private blood tests as part of routine wellness monitoring, particularly where NHS access may involve longer waiting times.
Practical Insight: If you have any of the above risk factors, regular blood marker monitoring may provide a useful health baseline and support more informed conversations with your healthcare team.
How Often Should You Consider Testing?
There is no single universal recommendation for the frequency of ovarian cancer marker testing outside of formal NHS screening protocols. However, for proactive health monitoring:
Our nurse-led team can discuss your testing options with you and provide your results with a clear, written report that you can share with your GP or appropriate specialist.
What Do Your Blood Test Results Mean?
Understanding your blood test report can feel overwhelming, but here is a straightforward guide:
If your CA-125 is within the normal range:
Results may be reassuring, but they do not completely exclude the possibility of ovarian conditions. Some ovarian cancers — particularly in early stages — may not produce elevated CA-125 levels.
If your CA-125 is elevated:
An elevated result can suggest a range of conditions, both benign and more serious. A raised CA-125 may indicate endometriosis, pelvic infection, fibroids, or other gynaecological conditions, not exclusively cancer. Elevated results should prompt a follow-up discussion with your GP or an appropriate healthcare professional.
Practical Insight: No single blood test result should be used to reach a self-diagnosis. Results are most valuable when considered alongside your personal health history, symptoms, and professional clinical assessment.
Private Blood Testing in London: Your Options
At Private Blood Tests London, we provide fast, accessible, nurse-led blood testing in a professional clinical environment. As a private clinic, we offer:
For Londoners who want to take control of their health screening proactively, private blood testing may offer a convenient option for proactive health monitoring, subject to individual clinical suitability. You can explore our women's health blood tests and cancer marker profiles available at our clinic.
If you are comparing private testing with NHS provision, it is worth noting that NHS ovarian cancer screening is typically offered in specific risk-based contexts. Private testing provides flexibility for those who wish to monitor their health outside of referral pathways, without replacing NHS care.
Frequently Asked Questions (FAQ)
1. What blood test is used for ovarian cancer detection?
The most commonly used blood test for ovarian cancer detection is the CA-125 test, which measures levels of a protein that may be elevated in certain ovarian conditions. HE4 is sometimes tested alongside CA-125 to provide broader information. Other markers such as AFP and hCG may be relevant in specific tumour subtypes. Results should always be reviewed in context with your overall health history.
2. Can a CA-125 blood test diagnose ovarian cancer?
No. A CA-125 blood test cannot diagnose ovarian cancer on its own. Elevated levels may be caused by a wide range of benign conditions, including endometriosis, fibroids, and pelvic infections. The test is best used as part of a broader clinical assessment. If your result is elevated, your healthcare professional may recommend further investigation.
3. Is the CA-125 test available privately in London?
Yes. The CA-125 test is available as a private blood test at our London clinic without a GP referral. Results are provided with a written clinical report that you can share with your healthcare team. We offer convenient appointments, often available on the same day.
4. What is considered a normal CA-125 level?
A normal CA-125 level is generally accepted as below 35 U/mL, though reference ranges can vary between laboratories. Levels above this threshold do not automatically indicate cancer and may reflect other gynaecological or inflammatory conditions. Levels within the normal range do not completely rule out ovarian conditions in all cases.
5. Who should get an ovarian cancer blood test?
Women with a family history of ovarian or breast cancer, those carrying BRCA gene mutations, post-menopausal women experiencing unexplained symptoms, or individuals who simply wish to monitor their health proactively may benefit from ovarian cancer marker testing. Suitability for specific tests depends on individual clinical circumstances; our nurse-led team can discuss the most appropriate options with you. Testing is available without a referral at our London clinic.
6. How long does it take to receive blood test results?
At Private Blood Tests London, results are typically available within 24–48 hours of your sample being processed, depending on the test. You will receive a written results report that you can share with your GP or appropriate healthcare professional for further discussion.
7. Can a normal CA-125 result mean I don't have ovarian cancer?
A normal CA-125 result is generally reassuring, but it does not definitively exclude ovarian cancer, particularly in early stages. Some ovarian cancers do not significantly elevate CA-125 levels. If you have ongoing symptoms or concerns, it is important to discuss these with an appropriate healthcare professional regardless of your result.
8. Does the NHS offer routine ovarian cancer blood testing?
The NHS does not currently offer a routine ovarian cancer screening programme for the general population. NHS testing is typically conducted in specific clinical contexts — for example, when symptoms are present or in high-risk groups. Private blood testing provides an option for those who wish to screen proactively outside of referral pathways.
9. Can men be tested for CA-125?
While CA-125 is primarily associated with gynaecological health, it is a non-gender-specific protein. However, it is not commonly used in male health screening. If you have specific concerns about cancer markers, our nurse-led team can discuss the most relevant tests for your individual health context.
10. Can I book a cancer marker blood test in London without a referral?
Yes. At Private Blood Tests London, you can book a cancer marker blood test in London without a GP referral. Our nurse-led clinic provides straightforward, professional testing and reporting. We do not offer treatment or prescriptions — we provide your results so that you can make informed decisions with your healthcare team.
A Note on Authority and Evidence
The information in this article is grounded in established UK clinical guidance and evidence-based understanding of gynaecological health biomarkers. Cancer marker blood tests are a recognised component of ovarian health monitoring, widely discussed in NHS, NICE, and Cancer Research UK literature. Our clinic follows current UK healthcare communication standards, and all testing is conducted by qualified nursing professionals in a compliant clinical environment.
Take a Proactive Step Towards Your Health
Understanding the role of blood tests in ovarian cancer detection is a valuable part of informed health awareness. If you would like to explore your options, book a blood test at our London clinic today. Our nurse-led team is here to provide professional, accessible testing and clear reporting — supporting your health journey at your own pace.
You can also learn more about our full range of women's health screening tests and cancer marker profiles available at Private Blood Tests London.
Disclaimer
This article is intended for educational and informational purposes only. The content does not constitute medical advice, diagnosis, or a recommendation for any specific treatment or course of action. Blood test results and biomarker levels should always be interpreted in the context of an individual's full clinical history and assessed by an appropriate, qualified healthcare professional.
Private Blood Tests London is a nurse-led testing and reporting service. We do not provide diagnosis, prescriptions, treatment, or specialist medical consultations. If you are experiencing symptoms that concern you, please contact your GP or an appropriate healthcare professional. In the event of a medical emergency, please contact 999 or attend your nearest A&E department.
This content has been written in accordance with GMC advertising guidance, CQC patient communication standards, and ASA guidelines for health-related content.
Written Date: 17 July 2026 Next Review Date: 17 July 2027